Axial involvement is present in approximately 25% of patients with PsA, with enthesitis, inflammatory bowel disease, and ...

Once-daily roflumilast cream 0.05% is safe and effective for atopic dermatitis (AD) in patients ages 2 to 5 years, according ...

Celltrion has launched Steqeyma (ustekinumab-stba), its biosimilar of Stelara (ustekinumab), at list price at an 85% discount ...

Rheumatic disorders affect 25% of people, with autoimmune diseases like rheumatoid arthritis and lupus impacting women of ...

STEQEYMA®, one of the first-wave biosimilars to STELARA®, is now available in the U.S.

The arrival of biosimilars like Celltrion's STEQEYMA and Biocon's YESINTEK is shaking up the psoriatic arthritis market, challenging blockbuster biologics with cost-effective alternatives. As ...

Overactive bladder (OAB) is associated with arthritis, with a positive association seen after adjustment for all covariates.

Three months after Bristol Myers Squibb revealed the success of two phase 3 trials of its oral targeted therapy Sotyktu in ...

FDA has authorized Hope Biosciences’ adipose-derived mesenchymal stem cells (HB-adMSCs) for use in the first pediatric ...

LAKE ZURICH, IL, USA I March 03, 2025 I Fresenius Kabi, an operating company of Fresenius, and Formycon AG, a leading, independent developer of high-quality ...